DIN 02508605 — MINT-OLOPATADINE 0.2% 0.2 %
MINT-OLOPATADINE 0.2% is a solution of Olopatadine marketed by MINT PHARMACEUTICALS INC. The full Olopatadine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02508605
- Brand name
- MINT-OLOPATADINE 0.2%
- Active ingredient
- Olopatadine
- Strength
- 0.2 %
- Dosage form
- SOLUTION
- Route
- OPHTHALMIC
- Manufacturer
- MINT PHARMACEUTICALS INC
- Health Canada status
- MARKETED
- Drug class
- Anti-allergy Agent (mast cell stabilizer / selective histamine H1 receptor antagonist)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Olopatadine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02305054 | APO-OLOPATADINE | 0.1 % | SOLUTION | APOTEX INC | DORMANT |
| 02402823 | APO-OLOPATADINE | 0.2 % | SOLUTION | APOTEX INC | DORMANT |
| 02458411 | JAMP-OLOPATADINE | 0.1 % | SOLUTION | JAMP PHARMA CORPORATION | DORMANT |
| 02422727 | MINT-OLOPATADINE | 0.1 % | SOLUTION | MINT PHARMACEUTICALS INC | MARKETED |
| 02521172 | OLOPATADINE | 0.1 % | SOLUTION | SANIS HEALTH INC | MARKETED |
| 02541653 | OLOPATADINE 0.2% | 0.2 % | SOLUTION | SANIS HEALTH INC | MARKETED |
| 02362171 | PATADAY | 0.2 % | SOLUTION | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |
| 02233143 | PATANOL | 0.1 % | SOLUTION | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |
| 02458551 | PAZEO | 0.7 % | SOLUTION | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |
| 02358913 | SANDOZ OLOPATADINE | 0.1 % | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02420171 | SANDOZ OLOPATADINE 0.2% | 0.2 % | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |